Nanalysis Scientific Corp.
NSCIF
$0.13
$0.016.08%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.71% | 10.34% | 21.97% | 20.86% | 50.53% |
| Total Depreciation and Amortization | -25.50% | 20.67% | 55.53% | 91.09% | -14.47% |
| Total Amortization of Deferred Charges | -6.50% | -28.14% | -53.65% | -74.42% | 0.33% |
| Total Other Non-Cash Items | 129.98% | 31.57% | 70.78% | 175.89% | 64.50% |
| Change in Net Operating Assets | 1,101.77% | -95.89% | 263.21% | 144.00% | 102.22% |
| Cash from Operations | 598.55% | 222.49% | 173.46% | 128.74% | 97.55% |
| Capital Expenditure | -2.93% | 14.78% | 84.72% | 92.32% | 63.36% |
| Sale of Property, Plant, and Equipment | 205.32% | 500.40% | 18,400.00% | 241.13% | -22.99% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | 100.00% |
| Other Investing Activities | 41.03% | 47.52% | 61.80% | 64.81% | 44.68% |
| Cash from Investing | 43.70% | 56.12% | 69.07% | 72.43% | 50.03% |
| Total Debt Issued | -15.53% | -31.96% | -80.81% | -84.68% | -73.11% |
| Total Debt Repaid | 30.93% | 38.28% | 45.42% | -4.14% | 43.39% |
| Issuance of Common Stock | -91.07% | -91.07% | -100.00% | 8.06% | 7.13% |
| Repurchase of Common Stock | -- | -1,900.00% | -1,900.00% | -1,900.00% | -1,900.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 50.21% | 49.26% | 42.26% | -0.36% | -11,687.50% |
| Cash from Financing | -101.95% | -187.11% | -132.64% | -106.56% | -84.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 118.83% | 80.06% | -1,396.05% | 121.47% | 84.54% |